The global spandex market, valued at almost $8 billion in December 2024, is projected to grow between 2% and 8% every year ...

What will be the significance of this month’s 50th anniversary meeting at the famed Pacific Grove conference centre in ...

DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic International Inc. (NASDAQ:DYAI) enters 2025 on the cusp of generating product revenues from its relationship with Proliant. Initially, commercialization ...

In addition, genetically modified plants may someday be used to produce recombinant vaccines ... hepatitis B virus (HBV), enterotoxigenic Escherichia coli (ETEC), and Norwalk virus.

Genetic engineering deployed to insert gene for human insulin into a bacterium, thus harnessing the substance for widespread use ...

The research combined cell-free DNA assembly ... Expression was performed in E. coli BL21 Star (DE3) on LB plates with 50 µg/mL kanamycin. Recombinant proteins were purified using Strep ...

The non-descript, pill-shaped cell is why we understand fundamental life processes (think DNA replication and transcription).

This important study presents compelling observational data supporting a role for transcription and polysome accumulation in the separation of newly replicated bacterial chromosomes. The study is ...

Authorities have indicated the cluster may be an outbreak of Shiga toxin-producing E coli, although testing has been inconclusive. The Department of Health said on Wednesday that it had not ...

Pharmaceutical giants Johnson & Johnson and Sanofi have stopped a late-stage clinical trial for their experimental E.coli vaccine after results failed to demonstrate sufficient efficacy.